Search

Mobile health (mHealth) applications (apps) have been recently introduced as an easily accessible tool for providing information to pregnant women with diabetes. Despite the growing number of apps on the topic "diabetes & pregnancy", a smartphone app offering comprehensive and individualized information to both women (before and during gestation) and their healthcare professionals was still missing. To overcome this lack, the Italian Diabetes and Pregnancy Study Group conceived and realized in 2016 a novel mobile app called "MySweetGestation". It is designed to be an interactive educational tool for both patients and physicians not expert in the field. Through an interactive way of learning, it provides validated information to the user, focusing on different area of interest: from prevention and risk factors for developing diabetes during pregnancy to treatment and follow-up strategies after gestation. Three years since its publication, MySweetGestation has been downloaded in different western and eastern countries worldwide, suggesting a widespread social impact. Easily accessible personalized information made available via mHealth technology may be of great importance to spread controlled information among the pregnant population. MySweetGestation, being an interactive educational device for both patients and healthcare professionals, may contribute to improve the management of pregnant women with diabetes.

279 Maternal serum A1C levels and triglycerides s predictive factors for LGA newborns in ype 1 diabetic women Elena Ciriello, Luisa Patane, Serena Pirola, Santa Barresi, iorgia Cavalli, Nicola Strobelt, Luigi Frigerio, Alessandro oberto Dodesini, Roberto Trevisan Ospedali Riuniti, Obstetrics and Gynecology, Bergamo, Italy, Ospedali Riuniti, Diabetology, Bergamo, Italy OBJECTIVE: The aim of the present study was to determine the role of etabolic maternal parameters in predicting large for gestational age LGA) neonates of women with type 1 diabetes mellitus (T1DM). STUDY DESIGN: We conducted a retrospective cohort study of a group of singleton pregnancy with T1DM who delivered in our hospital from June 2004 and June 2012. We compared maternal and fetal outcomes of women who delivered LGA with ones who had AGA newborns. Statistical analysis was performed with Fisher and T-test. RESULTS: A total of 80 women with T1DM delivered during the study eriod. Fifty-four (67%) women had AGA and 26 (33%) LGA babies. o differencies were found in maternal characteristics (maternal age, MI, duration of diabetes, pre-pregnancy diabetic complications, arity) in the study population. Metabolic parameters were evaluated onthly since 5th to 36th week. No significant correlations were ound between LGA rate and maternal total cholesterol or HDL choesterol levels and uric acid. Maternal A1C levels and fasting serum riglyceride were significantly higher in the second and in the third rimester in LGA group compared with other mothers (Table). CONCLUSION: These observations are in accordance with other reports and suggest that there is an association between A1C levels and heavier neonates in T1DM women. Maternal triglycerids may be considered a new predictor of neonatal birthweight. Lipid levels throughout pregnancy and their association need to be studied in women with type 1 diabetes mellitus.